Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition.

about

Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition.

Item

http://www.wikidata.org/entity/Q50199459

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition.

@en

Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition.

@nl

type

Item

label

Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition.

@en

Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition.

@nl

prefLabel

Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition.

@en

Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition.

@nl

P1476

Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition.

@en

P2093

Gulam Rabbani

http://www.w3.org/2001/XMLSchema#string

Inho Choi

http://www.w3.org/2001/XMLSchema#string

P2860

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

Molecular characterization of a protein-tyrosine-phosphatase enriched in striatum

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration

Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor

Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medications

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

The future of peptide-based drugs

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNAGI.2018.00021

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Khurshid Ahmad

Mohd Hassan Baig

P577

2018-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29467644

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5808296

http://www.w3.org/2001/XMLSchema#string